Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Bibliographic Details
Main Authors: Anniina Färkkilä, Doga C. Gulhan, Julia Casado, Connor A. Jacobson, Huy Nguyen, Bose Kochupurakkal, Zoltan Maliga, Clarence Yapp, Yu-An Chen, Denis Schapiro, Yinghui Zhou, Julie R. Graham, Bruce J. Dezube, Pamela Munster, Sandro Santagata, Elizabeth Garcia, Scott Rodig, Ana Lako, Dipanjan Chowdhury, Geoffrey I. Shapiro, Ursula A. Matulonis, Peter J. Park, Sampsa Hautaniemi, Peter K. Sorger, Elizabeth M. Swisher, Alan D. D’Andrea, Panagiotis A. Konstantinopoulos
Format: Article
Language:English
Published: Nature Portfolio 2020-05-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-16344-z
_version_ 1818421223588102144
author Anniina Färkkilä
Doga C. Gulhan
Julia Casado
Connor A. Jacobson
Huy Nguyen
Bose Kochupurakkal
Zoltan Maliga
Clarence Yapp
Yu-An Chen
Denis Schapiro
Yinghui Zhou
Julie R. Graham
Bruce J. Dezube
Pamela Munster
Sandro Santagata
Elizabeth Garcia
Scott Rodig
Ana Lako
Dipanjan Chowdhury
Geoffrey I. Shapiro
Ursula A. Matulonis
Peter J. Park
Sampsa Hautaniemi
Peter K. Sorger
Elizabeth M. Swisher
Alan D. D’Andrea
Panagiotis A. Konstantinopoulos
author_facet Anniina Färkkilä
Doga C. Gulhan
Julia Casado
Connor A. Jacobson
Huy Nguyen
Bose Kochupurakkal
Zoltan Maliga
Clarence Yapp
Yu-An Chen
Denis Schapiro
Yinghui Zhou
Julie R. Graham
Bruce J. Dezube
Pamela Munster
Sandro Santagata
Elizabeth Garcia
Scott Rodig
Ana Lako
Dipanjan Chowdhury
Geoffrey I. Shapiro
Ursula A. Matulonis
Peter J. Park
Sampsa Hautaniemi
Peter K. Sorger
Elizabeth M. Swisher
Alan D. D’Andrea
Panagiotis A. Konstantinopoulos
author_sort Anniina Färkkilä
collection DOAJ
description An amendment to this paper has been published and can be accessed via a link at the top of the paper.
first_indexed 2024-12-14T13:06:57Z
format Article
id doaj.art-7abeb069106949588957c1f409b64b58
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-14T13:06:57Z
publishDate 2020-05-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-7abeb069106949588957c1f409b64b582022-12-21T23:00:18ZengNature PortfolioNature Communications2041-17232020-05-011111110.1038/s41467-020-16344-zAuthor Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä0Doga C. Gulhan1Julia Casado2Connor A. Jacobson3Huy Nguyen4Bose Kochupurakkal5Zoltan Maliga6Clarence Yapp7Yu-An Chen8Denis Schapiro9Yinghui Zhou10Julie R. Graham11Bruce J. Dezube12Pamela Munster13Sandro Santagata14Elizabeth Garcia15Scott Rodig16Ana Lako17Dipanjan Chowdhury18Geoffrey I. Shapiro19Ursula A. Matulonis20Peter J. Park21Sampsa Hautaniemi22Peter K. Sorger23Elizabeth M. Swisher24Alan D. D’Andrea25Panagiotis A. Konstantinopoulos26Dana-Farber Cancer InstituteHarvard Medical SchoolResearch Program in Systems Oncology, University of HelsinkiLaboratory of Systems Pharmacology, Harvard Medical SchoolDana-Farber Cancer InstituteDana-Farber Cancer InstituteLaboratory of Systems Pharmacology, Harvard Medical SchoolLaboratory of Systems Pharmacology, Harvard Medical SchoolLaboratory of Systems Pharmacology, Harvard Medical SchoolLaboratory of Systems Pharmacology, Harvard Medical SchoolTESARO: A GSK companyTESARO: A GSK companyTESARO: A GSK companyHelen Diller Family Comprehensive Cancer CenterBrigham and Women’s Hospital, Laboratory for Systems PharmacologyDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical SchoolDana-Farber Cancer InstituteDana-Farber Cancer InstituteDana-Farber Cancer InstituteDepartment of Biomedical Informatics, Harvard Medical SchoolResearch Program in Systems Oncology, University of HelsinkiLaboratory of Systems Pharmacology, Harvard Medical SchoolUniversity of WashingtonDana-Farber Cancer InstituteDana-Farber Cancer InstituteAn amendment to this paper has been published and can be accessed via a link at the top of the paper.https://doi.org/10.1038/s41467-020-16344-z
spellingShingle Anniina Färkkilä
Doga C. Gulhan
Julia Casado
Connor A. Jacobson
Huy Nguyen
Bose Kochupurakkal
Zoltan Maliga
Clarence Yapp
Yu-An Chen
Denis Schapiro
Yinghui Zhou
Julie R. Graham
Bruce J. Dezube
Pamela Munster
Sandro Santagata
Elizabeth Garcia
Scott Rodig
Ana Lako
Dipanjan Chowdhury
Geoffrey I. Shapiro
Ursula A. Matulonis
Peter J. Park
Sampsa Hautaniemi
Peter K. Sorger
Elizabeth M. Swisher
Alan D. D’Andrea
Panagiotis A. Konstantinopoulos
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
Nature Communications
title Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_full Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_fullStr Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_full_unstemmed Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_short Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
title_sort author correction immunogenomic profiling determines responses to combined parp and pd 1 inhibition in ovarian cancer
url https://doi.org/10.1038/s41467-020-16344-z
work_keys_str_mv AT anniinafarkkila authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT dogacgulhan authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT juliacasado authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT connorajacobson authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT huynguyen authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT bosekochupurakkal authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT zoltanmaliga authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT clarenceyapp authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT yuanchen authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT denisschapiro authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT yinghuizhou authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT juliergraham authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT brucejdezube authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT pamelamunster authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT sandrosantagata authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT elizabethgarcia authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT scottrodig authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT analako authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT dipanjanchowdhury authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT geoffreyishapiro authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT ursulaamatulonis authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT peterjpark authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT sampsahautaniemi authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT peterksorger authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT elizabethmswisher authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT alanddandrea authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer
AT panagiotisakonstantinopoulos authorcorrectionimmunogenomicprofilingdeterminesresponsestocombinedparpandpd1inhibitioninovariancancer